Cat. No.
MABL-3974
Application
functional assay, ELISA
Isotype
Engineer antibody
Species Reactivity
Human
Clone No.
NB2E9
From
Recombinant Antibody
Specificity
This antibody is specific for amino acids E2066 and R2150 of human Factor VIII.
Alternative Names
AHF; Coagulation factor VIII; Antihemophilic factor; Procoagulant component
UniProt
P00451
Immunogen
This antibody was raised from PMBCs from a hemophilia A patient with inhibitor LE.
Application Notes
Used in ELISA against recombinant human factor VIII; inhibits factor‑VIII‑vWF binding with IC50 of 0.25 μg/mL and suppresses up to 85% of factor VIII function (Jacquemin et al.,2000 PMID:10607698; Coxon et al.,2021 PMID:33973229). Original paper described immortalized patient B‑lymphocyte derived IgG4‑kappa antibody LE2E9 targeting FVIII C1 domain, exhibiting type‑2‑kinetics inhibition of co‑factor activity and blocking vWF binding; it failed to recognize Arg2150His substituted C1 domain.
Antibody First Published
Jacquemin et al. A human antibody directed to the factor VIII C1 domain inhibits factor VIII cofactor activity and binding to von Willebrand factor Blood. 2000 Jan 1;95(1):156-63. PMID:10607698
Note on publication
In the original paper, immortalization of the patient B lymphocytes provided a cell line producing an anti-fVIII IgG4kappa antibody, LE2E9, that inhibited fVIII cofactor activity, following type 2 kinetics and prevented fVIII binding to von Willebrand factor. Epitope mapping with recombinant fVIII fragments indicated that LE2E9 recognized the fVIII C1 domain, but not the Arg2150His-substituted C1 domain.
Size
100 μg Purified antibody.
Concentration
1 mg/ml.
Purification
Protein A affinity purified
Buffer
PBS with 0.02% Proclin 300.
Storage Recommendation
Store at 4⁰C for up to 3 months. For longer storage, aliquot and store at - 20⁰C.


